Yung Shin Pharmaceutical Ind is an API and finished-dose manufacturer based in United States. It holds 12 active US drug master files across a filed portfolio of 12 molecules.
| Molecule | Regulators | Docs |
|---|---|---|
| Cabazitaxel | US FDA | 1 |
| Cinacalcet | US FDA | 1 |
| Docetaxel | US FDA | 1 |
| Eletriptan | US FDA | 1 |
| Entecavir | US FDA | 1 |
| Famotidine | US FDA | 1 |
| Meclofenamic Acid | US FDA | 1 |
| Micafungin | US FDA | 1 |
| Omeprazole | US FDA | 1 |
| Paclitaxel | US FDA | 1 |
| Voriconazole | US FDA | 1 |
| Zoledronic Acid | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| NPRA (MY) | 15 | None |
Choose your molecules and target markets. Yung Shin Pharmaceutical Ind comes back tiered against every other supplier able to file there.
Start for free